Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3)

The objectives of the grant will be accomplished by supporting partnerships among basic and translational neuroscientists who are committed to advancing the discovery of in vivo physiological measures as tools for target validation and therapeutic development. 

Funding: no fixed limit 

Duration: 5 years

Research Authority due date: 10 days prior to submission 

LOI (encouraged) due dates: 21.1.23,21.5.23, 21.9.23, 21.1.24, 21.5.24, 21.9.24, 21.1.25, 20.5.25

Full proposal due dates:  21.2.23,21.6.23, 21.10.23, 21.2.24, 21.6.24, 21.10.24, 21.2.25, 20.6.25